{"id":990659,"date":"2026-08-05T22:20:15","date_gmt":"2026-08-06T02:20:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/"},"modified":"2026-08-05T22:20:15","modified_gmt":"2026-08-06T02:20:15","slug":"biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/","title":{"rendered":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WOBURN, Mass., Aug.  05, 2026  (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ: BFRI) (&#8220;Biofrontera&#8221; or the &#8220;Company&#8221;), a U.S. specialty dermatology company commercializing Ameluz<sup>\u00ae<\/sup> (aminolevulinic acid hydrochloride) Gel, 10% with the BF-RhodoLED<sup>\u00ae<\/sup> lamp for photodynamic therapy (PDT) of actinic keratosis, today announced that it will report financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026.<\/p>\n<p align=\"justify\">Management will host a conference call and webcast the same day at 10:00 a.m. Eastern Time to discuss the results and provide a business update.<\/p>\n<p>\n        <b>Conference Call and Webcast Details<\/b>\n      <\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">\n            <b>Detail<\/b>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">\n            <b>Information<\/b>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Date<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Thursday, August 13, 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Time<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">10:00 a.m. Eastern Time<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">U.S. \/ Canada toll-free<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">1-877-877-1275<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">International<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">1-412-858-5202<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">Webcast<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: top\">\n            <a href=\"https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=a2Bp6alz\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=a2Bp6alz<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <br \/>Participants dialing in by telephone should ask to be joined into the Biofrontera call. The webcast will be accessible beginning approximately 20 minutes prior to the start of the call.<\/p>\n<p>\n        <b>About Biofrontera Inc.<\/b>\n      <\/p>\n<p align=\"justify\">Biofrontera Inc. (NASDAQ: BFRI) is a U.S. specialty dermatology company focused on the treatment of dermatological conditions. The Company commercializes Ameluz<sup>\u00ae<\/sup> (aminolevulinic acid hydrochloride) Gel, 10%, together with the BF-RhodoLED<sup>\u00ae<\/sup> lamp, for photodynamic therapy (PDT) in the treatment of actinic keratosis. Biofrontera Inc. has been a standalone, publicly traded company since its 2021 IPO and operates a wholly owned subsidiary, Biofrontera Discovery GmbH, in Germany. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lFo0C_E6Dne1xtWWD0VhSJqtHWxcFz_ODC5UjTF3fq98xj2TojKJ9zJlH0Y9KpmRJ8e1nRWrwnMYZxpVSmsodbEg1mx7TEVdG8sZIuOV6HQ=\" rel=\"nofollow\" target=\"_blank\">www.biofrontera-us.com<\/a>.<\/p>\n<p>\n        <b>Investor Contact<\/b>\n      <\/p>\n<p>Ben Shamsian<br \/>Lytham Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BCIsv7fX14XXXefNnLgbJhsfnpXYMw0N0iQx4Yo6tFfWTbJA1DmNouHj0fiEUkeG45KnU_h5I52OSdGSdVmv8SgpV5TyKfsNuYaxPPAzMkP_XgUg3zyJWDn6YdVdtlLN\" rel=\"nofollow\" target=\"_blank\">shamsian@lythampartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDY4YTExYjAtYjlkMS00ZTQyLTlmNTUtNDE2ZDFiYzlkZmU5LTUwMDA4NTk2My0yMDI2LTA4LTA1LWVu\/tiny\/Biofrontera-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ: BFRI) (&#8220;Biofrontera&#8221; or the &#8220;Company&#8221;), a U.S. specialty dermatology company commercializing Ameluz\u00ae (aminolevulinic acid hydrochloride) Gel, 10% with the BF-RhodoLED\u00ae lamp for photodynamic therapy (PDT) of actinic keratosis, today announced that it will report financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026. Management will host a conference call and webcast the same day at 10:00 a.m. Eastern Time to discuss the results and provide a business update. Conference Call and Webcast Details Detail Information Date Thursday, August 13, 2026 Time 10:00 a.m. Eastern Time U.S. \/ Canada toll-free 1-877-877-1275 International 1-412-858-5202 Webcast https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=a2Bp6alz Participants dialing in by telephone &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-990659","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ: BFRI) (&#8220;Biofrontera&#8221; or the &#8220;Company&#8221;), a U.S. specialty dermatology company commercializing Ameluz\u00ae (aminolevulinic acid hydrochloride) Gel, 10% with the BF-RhodoLED\u00ae lamp for photodynamic therapy (PDT) of actinic keratosis, today announced that it will report financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026. Management will host a conference call and webcast the same day at 10:00 a.m. Eastern Time to discuss the results and provide a business update. Conference Call and Webcast Details Detail Information Date Thursday, August 13, 2026 Time 10:00 a.m. Eastern Time U.S. \/ Canada toll-free 1-877-877-1275 International 1-412-858-5202 Webcast https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=a2Bp6alz Participants dialing in by telephone &hellip; Continue reading &quot;Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-06T02:20:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026\",\"datePublished\":\"2026-08-06T02:20:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/\",\"name\":\"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\",\"datePublished\":\"2026-08-06T02:20:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/","og_locale":"en_US","og_type":"article","og_title":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk","og_description":"WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) &#8212; Biofrontera Inc. (NASDAQ: BFRI) (&#8220;Biofrontera&#8221; or the &#8220;Company&#8221;), a U.S. specialty dermatology company commercializing Ameluz\u00ae (aminolevulinic acid hydrochloride) Gel, 10% with the BF-RhodoLED\u00ae lamp for photodynamic therapy (PDT) of actinic keratosis, today announced that it will report financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026. Management will host a conference call and webcast the same day at 10:00 a.m. Eastern Time to discuss the results and provide a business update. Conference Call and Webcast Details Detail Information Date Thursday, August 13, 2026 Time 10:00 a.m. Eastern Time U.S. \/ Canada toll-free 1-877-877-1275 International 1-412-858-5202 Webcast https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=a2Bp6alz Participants dialing in by telephone &hellip; Continue reading \"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-06T02:20:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026","datePublished":"2026-08-06T02:20:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/","name":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==","datePublished":"2026-08-06T02:20:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNDU3MiM3NzYxNjI0IzUwMDA4NTk2Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biofrontera-inc-to-report-second-quarter-2026-financial-results-on-august-13-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/990659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=990659"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/990659\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=990659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=990659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=990659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}